We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Oklahoma City, Okla.-based American Health Partners Oklahoma was chosen by ThyroTec,
a New Jersey-based medical products development company, to launch a presence
in the market, establish brand equity, finalize product packaging and develop
and implement all sales and distribution functions for ThyroTest, a new FDA
approved, CLIA waived rapid hypothyroid diagnostic screening device.
Micro Therapeutics (MTI) has announced the consolidation of its global manufacturing
operations into a single manufacturing location at its headquarters in Irvine,
Calif., and the closure of its facility in Bochum, Germany, effective Dec. 30,
2004.
CoreValve has received approval from the German government - Bezirksregierung
Koln, state of Nordrhein-Westfalen, Cologne -- to immediately commence a clinical
trial of its proprietary ReValving System to nonsurgically replace diseased
aortic heart valves in 10 patients who are contraindicated for open-heart surgery.
NIR Diagnostics, a developer of near-infrared instruments, has completed a tax-assisted
financing for gross cash proceeds of $901,350, received from GTTS as part of
the company's participation in the Biotechnology Investment Fund Program, managed
by IATRA Management Services.
Bio-Rad, a multinational manufacturer and distributor of life science research
products and clinical diagnostics, has received marketing clearance from the
FDA for its BioPlex 2200 system, a new immunoassay platform that employs multiplexing
technology to analyze for multiple disease states from single patient samples.
Microvision has entered into a multiphase, exclusive
license and product development agreement with Ethicon Endo-Surgery, a subsidiary
of Johnson & Johnson, whereby Microvision and Ethicon Endo-Surgery will
collaborate to integrate Microvision's proprietary technology into certain medical
products.
Affymetrix has granted Veridex, a Johnson & Johnson company, long-term and
comprehensive access to its GeneChip technology to create and market in-vitro
diagnostics for cancer.
Roche Diagnostics has signed a new dual-source, three-year contract with Chicago-based
Consorta to provide hospital glucose meters, test strips, lancets and ancillary
connectivity solutions.
Cardima, developer of the INTELLITEMP and REVELATION series of cardiac interventional
systems for the treatment of atrial fibrillation, has received written notice
from Nasdaq that the company has regained compliance with Nasdaq Marketplace
Rule 4310(c)(2)(B).
Lumenis and OpusDent, Lumenis' dental laser division, have announced the FDA
clearance of the OpusDuo Er:YAG laser system for contact bone removal during
oral surgical and periodontal procedures.